Pyle disease

Pyle disease, also known as Pyle metaphyseal dysplasia or metaphyseal dysplasia of Pyle, is a rare autosomal recessive skeletal disorder characterized by marked widening (flaring) of the metaphyses of long bones, particularly around the knees, giving a distinctive 'Erlenmeyer flask' deformity on X-ray. The condition is caused by biallelic loss-of-function mutations in the SFRP4 gene, which encodes secreted frizzled-related protein 4, a modulator of the Wnt signaling pathway involved in bone metabolism. The disease primarily affects the skeletal system. The most prominent radiographic feature is massive cortical thinning and metaphyseal expansion of the long bones, especially the distal femur and proximal tibia. Patients may present with genu valgum (knock knees), limb pain, fractures due to cortical thinning, and sometimes mild cranial sclerosis. Unlike the closely related condition cranio-metaphyseal dysplasia, Pyle disease typically does not cause significant cranial nerve compression or facial bone overgrowth, though mild thickening of the skull base can occur. Dental anomalies and scoliosis have also been reported in some cases. Pyle disease is generally considered a relatively benign condition. Most affected individuals have a normal lifespan. There is no specific curative treatment; management is supportive and symptomatic, focusing on orthopedic interventions for skeletal deformities such as genu valgum, fracture management, and monitoring for potential complications. Genetic counseling is recommended for affected families. The condition is extremely rare, with fewer than 30 cases reported in the medical literature.

Common questions about Pyle disease